302 Found
pmc-enju-pas Home  

PMC:3312845 / 23715-24631 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T9454 0-10 RB denotes Previously
T9455 10-11 -COMMA- denotes ,
T9456 12-14 PRP denotes we
T9457 15-23 VB denotes reported
T9458 24-28 IN denotes that
T9459 29-35 NN denotes SMI-71
T9460 36-37 -LRB- denotes (
T9461 37-39 DT denotes an
T9462 40-51 JJ denotes endothelial
T9463 52-59 NN denotes barrier
T9464 60-67 NN denotes antigen
T9465 67-68 -RRB- denotes )
T9466 69-85 NN denotes immunoreactivity
T9467 86-95 VB denotes decreased
T9468 96-98 IN denotes in
T9469 99-102 DT denotes the
T9470 103-105 NN denotes PC
T9471 106-107 CD denotes 1
T9472 108-111 NN denotes day
T9473 112-117 IN denotes after
T9474 118-120 NN denotes SE
T9475 121-122 -LRB- denotes [
T9476 122-123 CD denotes 5
T9477 123-124 -RRB- denotes ]
T9478 126-135 RB denotes Similarly
T9479 135-136 -COMMA- denotes ,
T9480 137-139 IN denotes in
T9481 140-141 CD denotes 1
T9482 142-150 JJ denotes day-post
T9483 151-153 NN denotes SE
T9484 154-161 NN denotes animals
T9485 162-164 IN denotes of
T9486 165-168 DT denotes the
T9487 169-183 JJ denotes saline-infused
T9488 184-189 NN denotes group
T9489 189-190 -COMMA- denotes ,
T9490 191-195 NN denotes loss
T9491 196-198 IN denotes of
T9492 199-205 NN denotes SMI-71
T9493 206-222 NN denotes immunoreactivity
T9494 223-226 VB denotes was
T9495 227-235 VB denotes detected
T9496 236-238 IN denotes in
T9497 239-244 NN denotes layer
T9498 245-251 CD denotes III/IV
T9499 252-254 IN denotes of
T9500 255-258 DT denotes the
T9501 259-261 NN denotes PC
T9502 262-264 IN denotes as
T9503 265-273 VB denotes compared
T9504 274-276 TO denotes to
T9505 277-283 JJ denotes non-SE
T9506 284-291 NN denotes animals
T9507 292-293 -LRB- denotes (
T9508 293-300 NN denotes Figures
T9509 301-303 NN denotes 4B
T9510 304-307 CC denotes and
T9511 308-312 NN denotes 5C-E
T9512 312-313 -COMMA- denotes ,
T9513 314-315 NN denotes p
T9514 316-317 SYM denotes <
T9515 318-322 CD denotes 0.05
T9516 322-323 -RRB- denotes )
T9517 325-329 RB denotes Thus
T9518 329-330 -COMMA- denotes ,
T9519 331-335 NN denotes loss
T9520 336-338 IN denotes of
T9521 339-345 NN denotes SMI-71
T9522 346-362 NN denotes immunoreactivity
T9523 363-373 VB denotes correlated
T9524 374-378 IN denotes with
T9525 379-385 NN denotes volume
T9526 386-388 IN denotes of
T9527 389-398 JJ denotes vasogenic
T9528 399-404 NN denotes edema
T9529 405-414 VB denotes following
T9530 415-417 NN denotes SE
T9531 419-423 DT denotes This
T9532 424-433 NN denotes reduction
T9533 434-436 IN denotes in
T9534 437-443 NN denotes SMI-71
T9535 444-447 VB denotes was
T9536 448-459 VB denotes accompanied
T9537 460-462 IN denotes by
T9538 463-472 VB denotes increased
T9539 473-483 NN denotes p65-Thr435
T9540 484-499 NN denotes phosphorylation
T9541 500-501 -LRB- denotes (
T9542 501-508 NN denotes Figures
T9543 509-513 NN denotes 5C-D
T9544 513-514 -RRB- denotes )
T9545 516-525 RB denotes Therefore
T9546 525-526 -COMMA- denotes ,
T9547 527-530 DT denotes the
T9548 531-537 NN denotes degree
T9549 538-540 IN denotes of
T9550 541-547 NN denotes SMI-71
T9551 548-564 NN denotes immunoreactivity
T9552 565-568 VB denotes was
T9553 569-578 RB denotes inversely
T9554 579-589 VB denotes correlated
T9555 590-592 TO denotes to
T9556 593-603 NN denotes p65-Thr435
T9557 604-619 NN denotes phosphorylation
T9558 620-624 IN denotes with
T9559 625-626 DT denotes a
T9560 627-633 JJ denotes linear
T9561 634-645 NN denotes coefficient
T9562 646-648 IN denotes of
T9563 649-660 NN denotes correlation
T9564 661-663 IN denotes of
T9565 664-671 CD denotes -0.6324
T9566 672-673 -LRB- denotes (
T9567 673-674 NN denotes p
T9568 675-676 SYM denotes <
T9569 677-681 CD denotes 0.05
T9570 681-682 -COLON- denotes ;
T9571 683-689 NN denotes Figure
T9572 690-692 NN denotes 4C
T9573 692-693 -RRB- denotes )
T9574 695-697 IN denotes In
T9575 698-706 NN denotes addition
T9576 706-707 -COMMA- denotes ,
T9577 708-716 NN denotes sTNFp55R
T9578 717-725 NN denotes infusion
T9579 726-737 RB denotes effectively
T9580 738-748 VB denotes alleviated
T9581 749-759 NN denotes p65-Thr435
T9582 760-775 NN denotes phosphorylation
T9583 776-779 CC denotes and
T9584 780-789 VB denotes preserved
T9585 790-796 NN denotes SMI-71
T9586 797-813 NN denotes immunoreactivity
T9587 814-816 IN denotes in
T9588 817-828 JJ denotes endothelial
T9589 829-834 NN denotes cells
T9590 835-844 VB denotes following
T9591 845-847 NN denotes SE
T9592 847-848 -COMMA- denotes ,
T9593 849-851 IN denotes as
T9594 852-860 VB denotes compared
T9595 861-863 TO denotes to
T9596 864-870 NN denotes saline
T9597 871-879 NN denotes infusion
T9598 880-881 -LRB- denotes (
T9599 881-882 NN denotes p
T9600 883-884 SYM denotes <
T9601 885-889 CD denotes 0.05
T9602 889-890 -COLON- denotes ;
T9603 891-898 NN denotes Figures
T9604 899-903 NN denotes 4A-B
T9605 903-904 -COMMA- denotes ,
T9606 905-907 NN denotes 5D
T9607 908-911 CC denotes and
T9608 912-914 NN denotes 5F
T9609 914-915 -RRB- denotes )
R7643 T9456 T9457 arg1Of we,reported
R7644 T9457 T9454 arg1Of reported,Previously
R7645 T9457 T9455 arg1Of reported,","
R7646 T9459 T9460 arg1Of SMI-71,(
R7647 T9464 T9460 arg2Of antigen,(
R7648 T9464 T9461 arg1Of antigen,an
R7649 T9464 T9462 arg1Of antigen,endothelial
R7650 T9464 T9463 arg1Of antigen,barrier
R7651 T9465 T9460 arg3Of ),(
R7652 T9466 T9459 arg1Of immunoreactivity,SMI-71
R7653 T9466 T9467 arg1Of immunoreactivity,decreased
R7654 T9467 T9457 arg2Of decreased,reported
R7655 T9467 T9458 arg1Of decreased,that
R7656 T9467 T9468 arg1Of decreased,in
R7657 T9467 T9473 arg1Of decreased,after
R7658 T9472 T9468 arg2Of day,in
R7659 T9472 T9469 arg1Of day,the
R7660 T9472 T9470 arg1Of day,PC
R7661 T9472 T9471 arg1Of day,1
R7662 T9474 T9473 arg2Of SE,after
R7663 T9474 T9475 arg1Of SE,[
R7664 T9476 T9475 arg2Of 5,[
R7665 T9477 T9475 arg3Of ],[
R7666 T9484 T9480 arg2Of animals,in
R7667 T9484 T9481 arg1Of animals,1
R7668 T9484 T9482 arg1Of animals,day-post
R7669 T9484 T9483 arg1Of animals,SE
R7670 T9484 T9485 arg1Of animals,of
R7671 T9488 T9485 arg2Of group,of
R7672 T9488 T9486 arg1Of group,the
R7673 T9488 T9487 arg1Of group,saline-infused
R7674 T9490 T9491 arg1Of loss,of
R7675 T9490 T9494 arg1Of loss,was
R7676 T9490 T9495 arg2Of loss,detected
R7677 T9493 T9491 arg2Of immunoreactivity,of
R7678 T9493 T9492 arg1Of immunoreactivity,SMI-71
R7679 T9495 T9478 arg1Of detected,Similarly
R7680 T9495 T9479 arg1Of detected,","
R7681 T9495 T9480 arg1Of detected,in
R7682 T9495 T9489 arg1Of detected,","
R7683 T9495 T9494 arg2Of detected,was
R7684 T9495 T9496 arg1Of detected,in
R7685 T9497 T9496 arg2Of layer,in
R7686 T9497 T9498 arg1Of layer,III/IV
R7687 T9497 T9499 arg1Of layer,of
R7688 T9501 T9499 arg2Of PC,of
R7689 T9501 T9500 arg1Of PC,the
R7690 T9502 T9495 arg3Of as,detected
R7691 T9503 T9502 arg2Of compared,as
R7692 T9503 T9504 arg1Of compared,to
R7693 T9506 T9504 arg2Of animals,to
R7694 T9506 T9505 arg1Of animals,non-SE
R7695 T9506 T9507 arg1Of animals,(
R7696 T9509 T9510 arg1Of 4B,and
R7697 T9510 T9507 arg2Of and,(
R7698 T9510 T9508 arg1Of and,Figures
R7699 T9510 T9512 arg1Of and,","
R7700 T9511 T9510 arg2Of 5C-E,and
R7701 T9513 T9512 arg2Of p,","
R7702 T9513 T9514 arg1Of p,<
R7703 T9513 T9515 arg1Of p,0.05
R7704 T9516 T9507 arg3Of ),(
R7705 T9519 T9520 arg1Of loss,of
R7706 T9519 T9523 arg1Of loss,correlated
R7707 T9522 T9520 arg2Of immunoreactivity,of
R7708 T9522 T9521 arg1Of immunoreactivity,SMI-71
R7709 T9523 T9517 arg1Of correlated,Thus
R7710 T9523 T9518 arg1Of correlated,","
R7711 T9523 T9524 arg1Of correlated,with
R7712 T9525 T9524 arg2Of volume,with
R7713 T9525 T9526 arg1Of volume,of
R7714 T9528 T9526 arg2Of edema,of
R7715 T9528 T9527 arg1Of edema,vasogenic
R7716 T9528 T9529 arg1Of edema,following
R7717 T9530 T9529 arg2Of SE,following
R7718 T9532 T9531 arg1Of reduction,This
R7719 T9532 T9533 arg1Of reduction,in
R7720 T9532 T9535 arg1Of reduction,was
R7721 T9532 T9536 arg2Of reduction,accompanied
R7722 T9534 T9533 arg2Of SMI-71,in
R7723 T9536 T9535 arg2Of accompanied,was
R7724 T9540 T9536 arg1Of phosphorylation,accompanied
R7725 T9540 T9537 arg2Of phosphorylation,by
R7726 T9540 T9538 arg2Of phosphorylation,increased
R7727 T9540 T9539 arg1Of phosphorylation,p65-Thr435
R7728 T9540 T9541 arg1Of phosphorylation,(
R7729 T9543 T9541 arg2Of 5C-D,(
R7730 T9543 T9542 arg1Of 5C-D,Figures
R7731 T9544 T9541 arg3Of ),(
R7732 T9548 T9547 arg1Of degree,the
R7733 T9548 T9549 arg1Of degree,of
R7734 T9548 T9552 arg1Of degree,was
R7735 T9548 T9554 arg2Of degree,correlated
R7736 T9551 T9549 arg2Of immunoreactivity,of
R7737 T9551 T9550 arg1Of immunoreactivity,SMI-71
R7738 T9554 T9545 arg1Of correlated,Therefore
R7739 T9554 T9546 arg1Of correlated,","
R7740 T9554 T9552 arg2Of correlated,was
R7741 T9554 T9553 arg1Of correlated,inversely
R7742 T9554 T9555 arg1Of correlated,to
R7743 T9554 T9558 arg1Of correlated,with
R7744 T9554 T9566 arg1Of correlated,(
R7745 T9557 T9555 arg2Of phosphorylation,to
R7746 T9557 T9556 arg1Of phosphorylation,p65-Thr435
R7747 T9561 T9558 arg2Of coefficient,with
R7748 T9561 T9559 arg1Of coefficient,a
R7749 T9561 T9560 arg1Of coefficient,linear
R7750 T9561 T9562 arg1Of coefficient,of
R7751 T9561 T9564 arg1Of coefficient,of
R7752 T9563 T9562 arg2Of correlation,of
R7753 T9565 T9564 arg2Of -0.6324,of
R7754 T9567 T9566 arg2Of p,(
R7755 T9567 T9568 arg1Of p,<
R7756 T9567 T9569 arg1Of p,0.05
R7757 T9567 T9570 arg1Of p,;
R7758 T9572 T9570 arg2Of 4C,;
R7759 T9572 T9571 arg1Of 4C,Figure
R7760 T9573 T9566 arg3Of ),(
R7761 T9575 T9574 arg2Of addition,In
R7762 T9578 T9577 arg1Of infusion,sTNFp55R
R7763 T9578 T9580 arg1Of infusion,alleviated
R7764 T9580 T9574 arg1Of alleviated,In
R7765 T9580 T9576 arg1Of alleviated,","
R7766 T9580 T9579 arg1Of alleviated,effectively
R7767 T9580 T9592 arg1Of alleviated,","
R7768 T9580 T9593 arg1Of alleviated,as
R7769 T9582 T9581 arg1Of phosphorylation,p65-Thr435
R7770 T9582 T9583 arg1Of phosphorylation,and
R7771 T9583 T9580 arg2Of and,alleviated
R7772 T9583 T9587 arg1Of and,in
R7773 T9586 T9583 arg2Of immunoreactivity,and
R7774 T9586 T9584 arg2Of immunoreactivity,preserved
R7775 T9586 T9585 arg1Of immunoreactivity,SMI-71
R7776 T9589 T9587 arg2Of cells,in
R7777 T9589 T9588 arg1Of cells,endothelial
R7778 T9589 T9590 arg1Of cells,following
R7779 T9591 T9590 arg2Of SE,following
R7780 T9594 T9593 arg2Of compared,as
R7781 T9594 T9595 arg1Of compared,to
R7782 T9597 T9595 arg2Of infusion,to
R7783 T9597 T9596 arg1Of infusion,saline
R7784 T9597 T9598 arg1Of infusion,(
R7785 T9599 T9598 arg2Of p,(
R7786 T9599 T9600 arg1Of p,<
R7787 T9599 T9601 arg1Of p,0.05
R7788 T9599 T9602 arg1Of p,;
R7789 T9604 T9605 arg1Of 4A-B,","
R7790 T9605 T9607 arg1Of ",",and
R7791 T9606 T9605 arg2Of 5D,","
R7792 T9607 T9602 arg2Of and,;
R7793 T9607 T9603 arg1Of and,Figures
R7794 T9608 T9607 arg2Of 5F,and
R7795 T9609 T9598 arg3Of ),(